Medpace Holdings (MEDP) Peer Comparison

$618.66

up-down-arrow $-15.32 (-2.42%)

As on 20-Nov-2026 12:36EST

Market cap

info icon

$18,292 Mln

Revenue (TTM)

info icon

$2,838 Mln

P/E Ratio

info icon

36.3

P/B Ratio

info icon

31.4

Div. Yield

info icon

0 %

Edit peer-selector-edit
Medpace Holdings (MEDP) Ascendis Pharma A/S - ADR Exelixis (EXEL) Halozyme Therapeutics (HALO) Kymera Therapeutics (KYMR)
Market cap ($ Mln)
18,292 18,064 16,837 11,432 10,891
Revenue ($ Mln)
2,838 1,208 2,497 1,802 102
Net Profit ($ Mln)
517.83 890.37 885.14 485.42 -349.47
Net Margin (%)
18.24 73.69 35.45 26.93 -341.87
RoE (%)
87.53 88.40 46.96 -- -22.16
Price to Earnings
36.31 18.11 20.66 25.19 --
Price-To-Book
31.41 10.44 9.18 97.15 6.72

Income Statement ($ Mln)

Liabilities ($ Mln)

Assets ($ Mln)

Cashflow ($ Mln)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...